Treatment of hepatitis B virus (HBV) in the setting of HIV-HBV co-infection

Grants

Funding Acknowledgements

The junior author (DMI) is a recipient of a postgraduate scholarship from the National Health and Medical Research Council (NHMRC). The senior author (SRL) is an NHMRC practitioner fellow, and receives funding from the NHMRC, Alfred Foundation and National Institutes of Health (1 R01 AI060449). SRI. has received funding for research from Gilead Sciences and to attend conferences from Bristol Myers Squibb. She is a member of advisory boards for Gilead and Novartis.The authors have no potential conflict of interest to declare.